RITUXIMAB TREATMENT EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REFRACTORY TO STANDARD THERAPY IN THE LONG-TERM FOLLOW-UP

RITUXIMAB TREATMENT EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REFRACTORY TO STANDARD THERAPY IN THE LONG-TERM FOLLOW-UP

Objective. To evaluate the efficacy and safety of rituximab (RTM) treatment in the long-term follow-up of patients with systemic lupus erythematosus (SLE) refractory to standard therapy. Material and methods. RTM therapy was prescribed to 97 SLE patients with high disease activity and insufficient e...

Full description

Bibliographic Details
Main Authors: M. E. Tsanyan, S. K. Soloviev, A. V. Torgashina, E. N. Aleksandrova, S. G. Radenska-Lopovok, E. V. Nikolaeva, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2014-06-01
Series:Научно-практическая ревматология
Subjects:
systemic lupus erythematosus
rituximab
long-term follow-up
b-cells
depletion.
Online Access:https://rsp.mediar-press.net/rsp/article/view/1919

Internet

https://rsp.mediar-press.net/rsp/article/view/1919

Similar Items